Hippocampus is the brain area where aluminum (Al) accumulates in abundance and is widely associated with learning and memory. In the present study, we evaluate behavioral, tissue, and proteomic changes in the hippocampus of Wistar rats caused by exposure to doses that mimic human consumption of aluminum chloride (AlCl3) in urban areas. For this, male Wistar rats were divided into two groups: Control (distilled water) and AlCl3 (8.3 mg/kg/day), both groups were exposed orally for 60 days. After the Al exposure protocol, cognitive functions were assessed by the Water maze test, followed by a collection for analysis of the global proteomic profile of the hippocampus by mass spectrometry. Aside from proteomic analysis, we performed a histological analysis of the hippocampus, to the determination of cell body density by cresyl violet staining in Cornu Ammonis fields (CA) 1 and 3, and hilus regions. Our results indicated that exposure to low doses of aluminum chloride triggered a decreased cognitive performance in learning and memory, being associated with the deregulation of proteins expression, mainly those related to the regulation of the cytoskeleton, cellular metabolism, mitochondrial activity, redox regulation, nervous system regulation, and synaptic signaling, reduced cell body density in CA1, CA3, and hilus.
Book Brazil in Advancing Pharmacotherapy and Clinical Pharmacy in Latin America Proceedings of the Fourth Brazilian Congress of Pharmacotherapy and Clinical Pharmacy doi: 10.62922/4cbffc ISBN: 978-65-983944-2-4 Editors Wallace Entringer Bottacin – ORCID | Lattes | Google Scholar Thaís Teles de Souza – ORCID | Lattes Walleri Christini Torelli Reis – ORCID | Lattes | Google […]
28 December 2022 in Research, Society and Development
The life expectancy of the population has increased and improved over the years due to the quality of living conditions, housing and health. However, it is understandable that the elderly are susceptible to multiple diseases due to a variety of factors. It is known that due to the high prevalence of non-communicable chronic diseases, the use of drugs has increased significantly, accompanied by higher incidences of polypharmacy. Therefore, pharmaceutical care in elderly and polydrug populations is extremely important for monitoring, not only to promote the rational use of drugs, but also to provide better adherence to treatment and, consequently, better clinical and economic results. In this way, the present research is an integrative review to analyze evidence in the literature regarding the role of the clinical pharmacist in pharmaceutical care, as well as their interventions and the impacts caused on polymedicated elderly. For this, data collection was carried out from secondary sources, through a bibliographic survey in national and international databases. 834 articles were found, and only 20 studies were used for the present research. The results obtained in this study can demonstrate that the performance of pharmaceutical care and its intervention in geriatric and polymedicated patients can adjust doses, reduce drug interactions and reduce costs, in addition to improving the quality of life of these patients.